EC published the Delegated Regulation (EU) 2019/667 extending the dates of deferred application of the clearing obligation for certain over-the-counter (OTC) derivative contracts. Regulation 2019/667 amends the Delegated Regulations 2015/2205, 2016/592, and 2016/1178. Regulation 2019/667 shall enter into force on the day following that of its publication in the Official Journal of the European Union.
Regulations 2015/2205, 2016/592, and 2016/1178 specify, among others, the effective dates of the clearing obligation for contracts pertaining to the classes of OTC derivatives set out in the Annexes to the Regulations. These Regulations laid down deferred dates of application of the clearing obligation for OTC derivative contracts concluded between the counterparties that are part of the same group and where one counterparty is established in a third country and the other counterparty is established in the Union. As stated in the relevant recitals of these Regulations, those deferred dates were necessary to ensure that such OTC derivative contracts were not subject to the clearing obligation before the adoption of an implementing act pursuant to Article 13(2) of European Market Infrastructure Regulation, or EMIR (EU No 648/2012).
To date, no implementing act pursuant to Article 13(2) of EMIR has been adopted in relation to the clearing obligation. Therefore, the application of the clearing obligation to OTC derivative contracts should be further deferred for a defined period of time or until the adoption of those implementing acts. Regulations 2015/2205, 2016/592, and 2016/1178, therefore, have been amended accordingly. The first subparagraph in Article 3(2) of Regulations 2015/2205, 2016/592, and (2016/1178 has been replaced. In Regulations (EU) 2015/2205, (EU) 2016/592, and (EU) 2016/1178, the initial deferred dates of application were aligned with the date of application of the clearing obligation for counterparties in Category 4. Because the deferred dates of application should be further extended, that extension should also apply to Category 4 entities.
Related Link: Regulation (EU) 2019/667
Effective Date: April 30, 2019
Keywords: Europe, EU, Banking, Securities, OTC Derivatives, EMIR, Clearing Obligation, Deferred Dates, Regulation 2019/667, EC
Previous ArticleBoE Governor Outlines Work on Using Technology for Bank Supervision
MAS and Temasek jointly released a report to mark the successful conclusion of the fifth and final phase of Project Ubin, which focused on building a blockchain-based multi-currency payments network prototype.
PRA published a public working draft, or PWD, of version 1.2.0 of the BoE Insurance XBRL taxonomy, along with the related technical artefacts.
CPMI published a report that sets out nineteen building blocks for a global roadmap to improve cross-border payments.
EBA published phase 2 of the technical package on the reporting framework 2.10, providing the technical tools and specifications for implementation of EBA reporting requirements.
APRA updated the lists of the Direct to APRA (D2A) validation rules for authorized deposit-taking institutions, insurers, and superannuation entities.
PRA updated the statement that provides guidance to regulated firms on implementation of the EBA guidelines on reporting and disclosure of exposures subject to measures applied in response to the COVID-19 crisis.
EBA updated the 2019 list of closely correlated currencies that was originally published in December 2013.
ESMA published the final report on the guidelines on securitization repository data completeness and consistency thresholds.
FASB issued a proposed Accounting Standards Update that would grant insurance companies, adversely affected by the COVID-19 pandemic, an additional year to implement the Accounting Standards Update No. 2018-12 on targeted improvements to accounting for long-duration insurance contracts, or LDTI (Topic 944).
APRA updated the regulatory approach for loans subject to repayment deferrals amid the COVID-19 crisis.